Cargando…

Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the Literature

Objective. This review is to evaluate the diagnostic value of serum GPC3 for hepatocellular carcinoma (HCC) due to conflicting results reported. Methods. NCBI PubMed and Embase were comprehensively searched for studies that have used serum GPC3 level as a diagnostic index for HCC. The quality of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Sheng-Li, Fang, Xiefan, Huang, Zao-Zao, Liu, Xiang-Jie, Xiong, Zhi-Fan, Liu, Ping, Yao, Hong-Yi, Li, Chang-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214040/ https://www.ncbi.nlm.nih.gov/pubmed/25378766 http://dx.doi.org/10.1155/2014/127831

Ejemplares similares

Can glypican-3 be a disease-specific biomarker?
por: Chen, Chaolei, et al.
Publicado: (2017)

Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
por: Sun, Bin, et al.
Publicado: (2017)

Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma
por: Guo, Meng, et al.
Publicado: (2020)

Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma
por: Wang, Jian-Yao, et al.
Publicado: (2021)

Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
por: Lee, Hyun Jung, et al.
Publicado: (2014)

Glypican-3-targeted precision diagnosis of hepatocellular carcinoma on clinical sections with a supramolecular 2D imaging probe
por: Han, Hai-Hao, et al.
Publicado: (2018)

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
por: El-Saadany, Sherif, et al.
Publicado: (2018)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
por: Nishida, Takahiro, et al.
Publicado: (2019)

Prognostic evaluation of esophageal cancer patients with stages I-III
por: Qiu, Meng-jun, et al.
Publicado: (2020)

Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker
por: Levin, Rachel A., et al.
Publicado: (2018)

Dysplastic Nodules with Glypican-3 Positive Immunostaining: A Risk for Early Hepatocellular Carcinoma
por: Gong, Li, et al.
Publicado: (2014)

Glypicans
por: Filmus, Jorge, et al.
Publicado: (2008)

Glypican 3 as a Serum Marker for Hepatoblastoma
por: Zhou, Shengmei, et al.
Publicado: (2017)

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2016)

High copy number variations, particular transcription factors, and low immunity contribute to the stemness of prostate cancer cells
por: Dai, Zao, et al.
Publicado: (2021)

Safety and outcomes of cochlear implantation in the elderly: A review of recent literature
por: Yang, Zao, et al.
Publicado: (2016)

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
por: Zheng, Xiufeng, et al.
Publicado: (2022)

Prognosis of primary hepatic lymphoma: A US population-based analysis
por: Qiu, Meng-jun, et al.
Publicado: (2020)

Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis
por: Xiao, Wei-Kai, et al.
Publicado: (2014)

Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma
por: Liu, Peijun, et al.
Publicado: (2023)

Plasmodium parasite as an effective hepatocellular carcinoma antigen glypican-3 delivery vector
por: Liu, Quan, et al.
Publicado: (2017)

Integrative Analysis of Siglec-15 mRNA in Human Cancers Based on Data Mining
por: Li, Qiu-ting, et al.
Publicado: (2020)

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
por: Bell, Meghan M., et al.
Publicado: (2020)

Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis
por: Liu, Hong, et al.
Publicado: (2018)

The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
por: Wang, Sen, et al.
Publicado: (2019)

Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
por: Li, Yuanyuan, et al.
Publicado: (2019)

Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma
por: Zhao, Juan, et al.
Publicado: (2022)

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
por: Wang, Li, et al.
Publicado: (2016)

A Statistical Approach to the Diagnosis and Prediction of HCC Using CK19 and Glypican 3 Biomarkers
por: Burciu, Călin, et al.
Publicado: (2023)

KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer
por: Wang, Zao-Zao, et al.
Publicado: (2018)

Hepatitis B virus X protein disrupts the balance of the expression of circadian rhythm genes in hepatocellular carcinoma
por: YANG, SHENG-LI, et al.
Publicado: (2014)

Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients
por: Mauro, Montalbano, et al.
Publicado: (2023)

(18)F-FDG PET–CT Diagnosis of Tuberculosis in Celiac Lymph Nodes
por: Mao, Xi Bao, et al.
Publicado: (2020)

Expression of Glypican 3 Is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes
por: Rahbari, Mohammad, et al.
Publicado: (2019)

A glypican-3-derived peptide vaccine against hepatocellular carcinoma
por: Sawada, Yu, et al.
Publicado: (2012)

Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma
por: Zhang, Yi-Fan, et al.
Publicado: (2016)

Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma(☆)
por: Shih, Tsung-Chieh, et al.
Publicado: (2020)

Association between microRNA-527 and glypican-3 in hepatocellular carcinoma
por: Nomura, Kei, et al.
Publicado: (2021)

Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
por: Truong, Quach, et al.
Publicado: (2016)

Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver
por: Geramizadeh, Bita, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_40ohbnpfge51tnvm0ovdmug0d1